SIRT1 and Parkinson disease: These findings are consistent with previous studies demonstrating reduced SIRT1 expression in the substantia nigra of PD patients, where lower SIRT1 levels have been linked to greater dopaminergic neuronal loss and increased disease severity (Zhu et al., 2021; Li et al., 2023).